Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 2	2025-03-07		NCT06863506

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hunan Cancer Hospital - the Affiliated Cancer Hospital of Xiangya school of Medicine, Central South University	1
Second Affiliated Hospital, Zhejiang University, School of Medicine	561
Taizhou Hospital	28
West China Hospital	359
Zhengzhou University	21

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
2nd Affiliated Hospital, School of Medicine	Hangzhou	China	8